Transcat reports second quarter adjusted ebitda increase of 35.5% to $7.1 million on strong revenue growth and gross margin expansion

Rochester, n.y.--(business wire)--transcat, inc. (nasdaq: trns) (“transcat” or the “company”), a leading provider of accredited calibration, repair, inspection and laboratory instrument services and value-added distributor of professional grade handheld test, measurement and control instrumentation, today reported financial results for its second quarter ended september 25, 2021 (the “second quarter”) of fiscal year 2022, which ends march 26, 2022 (“fiscal 2022”). results include the previously
TRNS Ratings Summary
TRNS Quant Ranking